News & Analysis on Clinical Trial Services & Contract Research And Development
Japan's Nitto Denko has developed what it claims is the world's first biodegradable gene carrier that can be used to transfer foreign genes into animal cells. Because the polymer breaks down in the body, it exhibits extremely low cell toxicity yet is...
Amersham Bioscience has sold its Hoefer one-dimensional electrophoresis business to Harvard Biosciences for around $5.3 million (€4.4m) in cash.
Diversa has licensed a proprietary enzyme for the biocatalytic synthesis of an unidentified pharmaceutical intermediate to BASF.
A lactose product developed by DMV International of the Netherlands, Pharmatose DCL14, has properties that give it performance advantages over rival excipients used as filler/binders, according to the company.
It is already well established that microwave energy can be used to speed up the breakdown of protein molecules by enzymes, the first stage in protein identification. Now, a collaboration between two companies is looking to incorporate microwaves into...
German biopharmaceutical company Medigene has been granted a US patent covering a specific manufacturing process for viruses suited for the use in therapies and research.
An imaging system that promises to take the tedium out of protein crystallisation experiments made its European debut at last week's International Biotech conference in London, UK.
Japan's Sumitomo Chemical is absorbing its wholly-owned Sumika Fine Chemicals subsidiary and combining it with its own activities in this area to bolster its role as a supplier of pharmaceutical chemicals.
The innovation gap between the EU and the US will not be closed before 2010 if the present rate of progress continues, according to new figures contained in the Commission's European innovation scoreboard for 2003.